SILVER SPRING, Md.,
March 16, 2012 /PRNewswire/ --
Sunpeaks Ventures, Inc. (OTCBB: SNPK) announces that it has
initiated a review, through special outside counsel, in connection
with the high volume of trading and price rise in its common shares
on the OTC Bulletin Board.
The trading did not involve any shares held by current Sunpeaks
officers, directors, insiders or employees, as Mr. Barch is the
only insider who is a shareholder. All of Mr. Barch's shares
are restricted from trading under applicable federal securities
laws. Preliminary indications are that the recent trading
activity was conducted by persons unknown to current
management.
Sunpeaks welcomes that FINRA has commenced promptly an inquiry
into the trading, and the Company and Mr. Barch are cooperating
fully with the inquiry. FINRA is the largest independent
regulator for all securities firms doing business in the United States, overseeing brokerage firms
branch offices and registered securities representatives.
Sunpeaks and Mr. Barch stand fully behind the accuracy and content
of all press releases issued by the Company since February 29, 2012.
Sunpeaks also has become aware that internet newsletters have
been making unsupportable claims, inappropriate comparisons and
unjustifiable common stock performance projections about the
Company. The Company has not, does not and will not
communicate with publishers of internet newsletters about OTC
Bulletin Board stocks. Moreover, neither the Company nor
anyone associated with the Company has paid anyone to promote its
securities. Sunpeaks refers all potential investors to a
warning issued by the US Securities and Exchange Commission about
potentially misleading conduct in the promotion of stocks via the
internet. Consistent with the SEC's investor notice, Sunpeaks
cautions potential investors who are interested in information
about the Company to consider only information issued directly
by the Company in filings with the SEC and press releases published
by the Company.
The Company expressly disclaims any obligation in the future to
address in public announcements or otherwise unusual patterns of
trading in its common stock or unusual prices or price swings
thereof.
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary
Healthcare Distribution Specialists, LLC ("HDS"), is a nationally
focused, value-added distributor of specialty drugs and
over-the-counter ("OTC") branded multivitamins to the healthcare
provider market. HDS also owns and markets Clotamin®, a
specialized over-the-counter multivitamin product designed
exclusively for use by patients also on Warfarin®, a popular blood
thinner that has a long list of known adverse drug and food
interactions.
For additional information, please visit
www.sunpeaksventures.com.
Contact: Financial Insights 888-248-8491 or
info@sunpeaksventures.com
Safe Harbor Statement
Information in this document constitute forward-looking
statements or statements which may be deemed or construed to be
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. The words
"forecast", "anticipate", "estimate", "project", "intend",
"expect", "should", "believe", and similar expressions are intended
to identify forward-looking statements. These forward-looking
statements involve, and are subject to known and unknown risks,
uncertainties and other factors which could cause Sunpeaks
Ventures' actual results, performance (financial or operating) or
achievements to differ from the future results, performance
(financial or operating) or achievements expressed or implied by
such forward-looking statements. The risks, uncertainties and
other factors are more fully discussed in Sunpeaks Ventures'
filings with the U.S. Securities and Exchange Commission. All
forward-looking statements attributable to Sunpeaks Ventures herein
are expressly qualified in their entirety by the above-mentioned
cautionary statement. Sunpeaks Ventures disclaims any
obligation to update forward-looking statements contained in this
estimate, except as may be required by law.
SOURCE Sunpeaks Ventures, Inc.